- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Trial Details
Key Eligibility Criteria
1800 Participants Needed
Trial Details
Key Eligibility Criteria
100 Participants Needed
Trial Details
Key Eligibility Criteria
150 Participants Needed
Trial Details
Key Eligibility Criteria
16 Participants Needed
Trial Details
Key Eligibility Criteria
263 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
270 Participants Needed
Trial Details
Key Eligibility Criteria
150 Participants Needed
Trial Details
Key Eligibility Criteria
930 Participants Needed
Trial Details
Key Eligibility Criteria
380 Participants Needed
Trial Details
Key Eligibility Criteria
288 Participants Needed
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
420 Participants Needed
Trial Details
Key Eligibility Criteria
200 Participants Needed
Trial Details
Key Eligibility Criteria
100 Participants Needed
Trial Details
Key Eligibility Criteria
313 Participants Needed
Trial Details
Key Eligibility Criteria
20 Participants Needed
Trial Details
Key Eligibility Criteria
50 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
2300 Participants Needed
"I am an active athlete who is not ready or willing to stop my activities because of knee pain at 42. I have tried cortisone shots and found they only temporary mask the issue, or even cause more problems later. That's why I started researching medical studies."
"I’ve tried several meds without too much relief. Injections only work on my right knee but not much on the left knee. My pain is nearly unbearable at this point. Hoping to learn about what promising drugs exist in trials."
"I’m allergic to so many standard arthritis drugs, so I've been researching some of the newest ones still in the research phase. I'm hoping to find out if I'd be a good match—it would be great to find something that works (and, if not, at least contribute to the cause)."
"I've been 17+ years in pain with bilateral osteoarthritis. PRP and HA injections have not helped. Physical therapy has helped only to a certain degree. I'm looking for new treatment options before considering replacement. "
"I have been struggling with severe knee pain since my service in the military. I am only 52! I miss doing the things I used to do."
Trial Details
Key Eligibility Criteria
466 Participants Needed
Trial Details
Key Eligibility Criteria
4000 Participants Needed
Trial Details
Key Eligibility Criteria
4000 Participants Needed
Trial Details
Key Eligibility Criteria
4000 Participants Needed
Trial Details
Key Eligibility Criteria
90 Participants Needed
Trial Details
Key Eligibility Criteria
269 Participants Needed
Trial Details
Key Eligibility Criteria
584 Participants Needed
Trial Details
Key Eligibility Criteria
99 Participants Needed
Trial Details
Key Eligibility Criteria
540 Participants Needed
Trial Details
Key Eligibility Criteria
200 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Osteoarthritis trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Osteoarthritis is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added SL1002 for Osteoarthritis, Methylprednisolone for Knee Arthritis and Knee Braces for Osteoarthritis to the Power online platform.